↓ Skip to main content

Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, February 2014
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma
Published in
Journal of Experimental & Clinical Cancer Research, February 2014
DOI 10.1186/1756-9966-33-20
Pubmed ID
Authors

Xiaobin Cui, Zhimin Zhao, Dong Liu, Tao Guo, Su Li, Jianming Hu, Chunxia Liu, Lan Yang, Yuwen Cao, Jinfang Jiang, Weihua Liang, Wei Liu, Shugang Li, Lianghai Wang, Lidong Wang, Wenyi Gu, Chuanyue Wu, Yunzhao Chen, Feng Li

Abstract

Esophageal squamous cell carcinoma (ESCC) is an aggressive tumor with dismal prognosis and high incidence and mortality in Kazakh population. MiR-34a, a direct p53 target gene, possesses tumor-suppressive properties as they mediate apoptosis, cell cycle arrest, and senescence. The reduced expression of miR-34a by methylation in various cancers has been reported.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 5%
Unknown 20 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 19%
Student > Bachelor 3 14%
Other 2 10%
Student > Ph. D. Student 2 10%
Student > Master 2 10%
Other 2 10%
Unknown 6 29%
Readers by discipline Count As %
Agricultural and Biological Sciences 5 24%
Medicine and Dentistry 5 24%
Biochemistry, Genetics and Molecular Biology 2 10%
Chemical Engineering 1 5%
Psychology 1 5%
Other 1 5%
Unknown 6 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2015.
All research outputs
#22,756,649
of 25,371,288 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#1,967
of 2,378 outputs
Outputs of similar age
#208,445
of 238,193 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#9
of 11 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,378 research outputs from this source. They receive a mean Attention Score of 4.8. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 238,193 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.